Unicycive Therapeutics, Inc.

NASDAQ:UNCY

Biotechnology

Healthcare
$3.57 -3.40%

-$0.24 today

Market cap
$104.19M
Beta
1.73
P/E (TTM)
-40.8
EPS (TTM)
-$0.17
52W Low $3.71High $8.74

Volume 1.39M

Average 0.65M

UNCY EPS (Basic)

Net income attributable to common shareholders divided by the weighted average basic shares outstanding.

Unicycive Therapeutics, Inc.NASDAQ: UNCY

EPS (Basic) · Q1 FY2026 · quarter ended Mar 2026

EPS (Basic) turns negative

Q1 FY2026 EPS (Basic) was -$0.54, compared with $0.04 a year earlier. Trailing-twelve-month EPS (Basic) was -$2.05.

Context

  • EPS (Basic) grew in size in 2 of the last 3 fiscal years.

What to watch

Whether EPS (Basic) reaches the consensus estimate from 5 analysts of -$1.24 (+26.0%) for the fiscal year ending Dec 2026, a slowdown from the +70.2% reported in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
-$0.54+18.2% QoQ
Last fiscal yearDec 2025
-$1.67+70.2% YoY
LTMMar 2026
-$2.05+12.2% YoY
EPS (Basic) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-1327.3%+9.4%+1336.7 pp
1 year+70.2%+26.0%-44.2 pp
3-year CAGR———
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EPS (Basic) history

USD · from the income statement

Latest · FY2025
(1.67) USD
Year-over-year change
+70.2%
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EPS (Basic) vs competitors

How UNCY compares with its peers on the latest reported figures

  • Peers report in different currencies, so EPS (Basic) is compared through growth and rates rather than absolute size.
  • Its year-over-year change of +12.2% is the 8th highest of 10, against a peer median of +55.8%.
UNCY Competitors
EPS (Basic) for UNCY and competitors
Company Period LTM YoY 3-year CAGR
VXRTVaxart, Inc.LTM Mar 2026$0.14 USD+147.7%—
HYFTMindWalk Holdings Corp.LTM Jan 2026-CA$0.29 CAD+81.9%—
BMEABiomea Fusion, Inc.LTM Mar 2026-$0.89 USD+75.0%—
RLMDRelmada Therapeutics, Inc.LTM Mar 2026-$1.11 USD+55.8%—
PMVPPMV Pharmaceuticals, Inc.LTM Mar 2026-$1.49 USD-313.9%—
CBUSCibus, Inc.LTM Mar 2026-$1.77 USD+84.8%—
ACRVAcrivon Therapeutics, Inc. Common StockLTM Mar 2026-$2 USD+9.9%—
UNCYUnicycive Therapeutics, Inc.LTM Mar 2026-$2.05 USD+12.2%—
CAMPCAMP4 Therapeutics CorporationLTM Mar 2026-$2.27 USD+19.2%—
IMUXImmunic, Inc.LTM Mar 2026-$5.98 USD+39.0%—
Peer median (excluding UNCY) —+55.8%—

Competitors are the stored peer set for UNCY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue0951K675K00
Cost of Revenue0000572K
Gross Profit0951K675K0(572K)
Gross Margin—100.0%100.0%——
Research & Development6.08M12.44M12.9M20.01M9.12M
Selling, General & Admin2.9M6.57M8.55M12.1M20.4M
Operating Expenses8.98M19M21.45M32.12M28.95M
Depreciation & Amortization13K161K284K428K572K
EBITDA(9.38M)(17.89M)(30.18M)(36.23M)(25.91M)
EBITDA Margin—-1881.3%-4470.8%——
Operating Income(8.98M)(18.05M)(20.77M)(32.12M)(29.52M)
Operating Margin—-1898.2%-3077.6%——
Interest Income00615K1.26M1.01M
Interest Expense628K6K82K71K71K
Other Income / Expenses(1.04M)(6K)(9.77M)(4.61M)2.96M
Income Before Tax(10.02M)(18.06M)(30.54M)(36.73M)(26.56M)
Pre-Tax Margin—-1898.8%-4525.0%——
Income Tax Expense00000
Net Income(10.02M)(18.06M)(30.54M)(36.73M)(26.56M)
Net Margin—-1898.8%-4525.0%——
EPS (Basic)(8.60)(1.20)(1.28)(5.60)(1.67)
EPS (Diluted)(8.60)(1.20)(1.28)(5.60)(1.67)
Weighted Avg Shares1.17M1.51M2.45M6.7M158.87M
Weighted Avg Shares (Diluted)1.17M1.51M2.45M6.7M158.87M

Unicycive Therapeutics, Inc.

NASDAQ:UNCY

Intrinsic Alpha fair value

Locked

Current Price

$3.57

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.